196 related articles for article (PubMed ID: 37865511)
21. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
Aul C; Giagounidis A; Germing U; Ganser A
Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
23. The myelodysplastic syndromes.
Nguyen PL
Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
[TBL] [Abstract][Full Text] [Related]
24. World Health Organization classification of myelodysplastic syndromes.
Czader M; Orazi A
Curr Pharm Des; 2012; 18(22):3149-62. PubMed ID: 22571693
[TBL] [Abstract][Full Text] [Related]
25. Myelodysplastic Syndromes: Diagnosis and Treatment.
Steensma DP
Mayo Clin Proc; 2015 Jul; 90(7):969-83. PubMed ID: 26141335
[TBL] [Abstract][Full Text] [Related]
26. Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update.
Jain AG; Zhang L; Bennett JM; Komrokji R
Ann Lab Med; 2022 May; 42(3):299-305. PubMed ID: 34907099
[TBL] [Abstract][Full Text] [Related]
27. Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop.
Platzbecker U; Santini V; Mufti GJ; Haferlach C; Maciejewski JP; Park S; Solé F; van de Loosdrecht AA; Haase D
Leuk Res; 2012 Mar; 36(3):264-70. PubMed ID: 22137318
[TBL] [Abstract][Full Text] [Related]
28. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.
Montalban-Bravo G; Garcia-Manero G
Am J Hematol; 2018 Jan; 93(1):129-147. PubMed ID: 29214694
[TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic Syndromes: Updates and Nuances.
Dao KT
Med Clin North Am; 2017 Mar; 101(2):333-350. PubMed ID: 28189174
[TBL] [Abstract][Full Text] [Related]
30. Standardizing the initial evaluation for myelodysplastic syndromes.
Marshall D; Roboz GJ
Curr Hematol Malig Rep; 2013 Dec; 8(4):361-9. PubMed ID: 24178514
[TBL] [Abstract][Full Text] [Related]
31. [Current state of treatment for myelodysplastic syndromes].
Ichikawa M
Rinsho Ketsueki; 2023; 64(9):988-997. PubMed ID: 37793875
[TBL] [Abstract][Full Text] [Related]
32. [Molecular international prognostic scoring system for myelodysplastic syndromes].
Nagata Y
Rinsho Ketsueki; 2023; 64(5):355-368. PubMed ID: 37271526
[TBL] [Abstract][Full Text] [Related]
33. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
Patnaik MM; Lasho TL
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):450-459. PubMed ID: 33275756
[TBL] [Abstract][Full Text] [Related]
34. New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.
Tothova Z; Steensma DP; Ebert BL
Clin Cancer Res; 2013 Apr; 19(7):1637-43. PubMed ID: 23329810
[TBL] [Abstract][Full Text] [Related]
35. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886
[TBL] [Abstract][Full Text] [Related]
36. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
Nazha A; Sekeres MA
Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
[TBL] [Abstract][Full Text] [Related]
37. Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative.
Sekeres MA; Stowell SA; Berry CA; Mencia WM; Dancy JN
Leuk Res; 2013 Apr; 37(4):422-6. PubMed ID: 23306108
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related myelodysplastic syndromes, or are they?
Abou Zahr A; Kavi AM; Mukherjee S; Zeidan AM
Blood Rev; 2017 May; 31(3):119-128. PubMed ID: 27923516
[TBL] [Abstract][Full Text] [Related]
39. Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice.
Shallis RM; Xu ML; Podoltsev NA; Curtis SA; Considine BT; Khanna SR; Siddon AJ; Zeidan AM
Ann Hematol; 2018 Dec; 97(12):2333-2343. PubMed ID: 30109425
[TBL] [Abstract][Full Text] [Related]
40. The myelodysplastic syndromes: diagnosis and treatment.
Steensma DP; Bennett JM
Mayo Clin Proc; 2006 Jan; 81(1):104-30. PubMed ID: 16438486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
